News | March 23, 2024
USFDA grants ODD to Cevidoplenib for immune thrombocytopenia
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Operations of Line II was stopped due to a fire incident earlier
Hepatitis B infects over 40 million people in India
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Pharma Solutions operates 10 research and development and/or production sites globally
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Subscribe To Our Newsletter & Stay Updated
